vs
FLOWSERVE CORP（FLS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
FLOWSERVE CORP的季度营收约是Royalty Pharma plc的2.0倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -2.4%，领先36.8%），Royalty Pharma plc同比增速更快（4.8% vs 3.5%），过去两年FLOWSERVE CORP的营收复合增速更高（6.0% vs 4.6%）
Flowserve是美国跨国企业，也是全球领先的工业及环保机械供应商之一，主营泵、阀门、端面机械密封、自动化产品及相关服务，覆盖电力、油气、化工等多个行业，总部位于得克萨斯州欧文市，在全球50多国拥有近1.6万名员工，同时提供完善的售后服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FLS vs RPRX — 直观对比
营收规模更大
FLS
是对方的2.0倍
$622.0M
营收增速更快
RPRX
高出1.2%
3.5%
净利率更高
RPRX
高出36.8%
-2.4%
两年增速更快
FLS
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $-29.0M | $214.2M |
| 毛利率 | 34.8% | — |
| 营业利润率 | 3.5% | 62.4% |
| 净利率 | -2.4% | 34.4% |
| 营收同比 | 3.5% | 4.8% |
| 净利润同比 | -137.4% | 2.9% |
| 每股收益（稀释后） | $-0.21 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLSRPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.1B | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.2B | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润FLSRPRX
| Q4 25 | $-29.0M | $214.2M | ||
| Q3 25 | $219.6M | $288.2M | ||
| Q2 25 | $81.8M | $30.2M | ||
| Q1 25 | $73.9M | $238.3M | ||
| Q4 24 | $77.5M | $208.2M | ||
| Q3 24 | $58.4M | $544.0M | ||
| Q2 24 | $72.6M | $102.0M | ||
| Q1 24 | $74.2M | $4.8M |
毛利率FLSRPRX
| Q4 25 | 34.8% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 32.3% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 31.5% | — | ||
| Q2 24 | 31.6% | — | ||
| Q1 24 | 31.2% | — |
营业利润率FLSRPRX
| Q4 25 | 3.5% | 62.4% | ||
| Q3 25 | 6.7% | 70.1% | ||
| Q2 25 | 12.3% | 36.3% | ||
| Q1 25 | 11.5% | 94.0% | ||
| Q4 24 | 10.6% | 60.9% | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 10.5% | 50.2% | ||
| Q1 24 | 10.4% | -13.0% |
净利率FLSRPRX
| Q4 25 | -2.4% | 34.4% | ||
| Q3 25 | 18.7% | 47.3% | ||
| Q2 25 | 6.9% | 5.2% | ||
| Q1 25 | 6.5% | 41.9% | ||
| Q4 24 | 6.6% | 35.1% | ||
| Q3 24 | 5.2% | 96.3% | ||
| Q2 24 | 6.3% | 19.0% | ||
| Q1 24 | 6.8% | 0.8% |
每股收益（稀释后）FLSRPRX
| Q4 25 | $-0.21 | $0.49 | ||
| Q3 25 | $1.67 | $0.67 | ||
| Q2 25 | $0.62 | $0.07 | ||
| Q1 25 | $0.56 | $0.55 | ||
| Q4 24 | $0.59 | $0.46 | ||
| Q3 24 | $0.44 | $1.21 | ||
| Q2 24 | $0.55 | $0.23 | ||
| Q1 24 | $0.56 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $760.2M | $618.7M |
| 总债务越低越好 | $1.6B | $9.0B |
| 股东权益账面价值 | $2.2B | $9.7B |
| 总资产 | $5.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.72× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FLSRPRX
| Q4 25 | $760.2M | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $675.4M | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务FLSRPRX
| Q4 25 | $1.6B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.5B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益FLSRPRX
| Q4 25 | $2.2B | $9.7B | ||
| Q3 25 | $2.3B | $9.6B | ||
| Q2 25 | $2.2B | $9.5B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.1B | $10.3B | ||
| Q2 24 | $2.0B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产FLSRPRX
| Q4 25 | $5.7B | $19.6B | ||
| Q3 25 | $5.8B | $19.3B | ||
| Q2 25 | $5.7B | $18.3B | ||
| Q1 25 | $5.5B | $17.6B | ||
| Q4 24 | $5.5B | $18.2B | ||
| Q3 24 | $5.3B | $18.0B | ||
| Q2 24 | $5.2B | $17.7B | ||
| Q1 24 | $5.1B | $16.1B |
负债/权益比FLSRPRX
| Q4 25 | 0.72× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.75× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-174.0K | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | — |
| 自由现金流率自由现金流/营收 | -2.1% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $435.0M | — |
8季度趋势，按日历期对齐
经营现金流FLSRPRX
| Q4 25 | $-174.0K | $827.1M | ||
| Q3 25 | $401.8M | $702.6M | ||
| Q2 25 | $154.1M | $364.0M | ||
| Q1 25 | $-49.9M | $596.1M | ||
| Q4 24 | $197.3M | $742.5M | ||
| Q3 24 | $178.5M | $703.6M | ||
| Q2 24 | $-12.8M | $658.2M | ||
| Q1 24 | $62.3M | $664.6M |
自由现金流FLSRPRX
| Q4 25 | $-25.6M | — | ||
| Q3 25 | $384.7M | — | ||
| Q2 25 | $137.5M | — | ||
| Q1 25 | $-61.7M | — | ||
| Q4 24 | $168.5M | — | ||
| Q3 24 | $154.6M | — | ||
| Q2 24 | $-27.5M | — | ||
| Q1 24 | $48.6M | — |
自由现金流率FLSRPRX
| Q4 25 | -2.1% | — | ||
| Q3 25 | 32.8% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | -5.4% | — | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | -2.4% | — | ||
| Q1 24 | 4.5% | — |
资本支出强度FLSRPRX
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 1.3% | — |
现金转化率FLSRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 1.83× | 2.44× | ||
| Q2 25 | 1.89× | 12.06× | ||
| Q1 25 | -0.68× | 2.50× | ||
| Q4 24 | 2.55× | 3.57× | ||
| Q3 24 | 3.06× | 1.29× | ||
| Q2 24 | -0.18× | 6.45× | ||
| Q1 24 | 0.84× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLS
| Aftermarket Equipment | $563.4M | 46% |
| FCD | $390.3M | 32% |
| Original Equipment | $268.5M | 22% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
